ArticleOncology letters2016

Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis.

Feng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.